It’s great to see we have once again been recognised by the @FT as one of Europe’s Leading Patent Law Firms! Highly… https://t.co/laZ3VF0ER0

Why was Novartis refused a preliminary injunction to keep Teva and four other generics off the market for its MS tr… https://t.co/CrNAoyQhob